arrow
A

Alfredo Tagarro

nfanta sofia university hospital and henares hospital
H指数:25
被引数:2,156

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Pharmacokinetics of abacavir and lamivudine in infants living with HIV with and without rifampicin co-treatment

HIV感染者婴儿中阿巴卡韦和拉米夫定的药代动力学研究(联合或不联合利福平治疗)

2026-08-200
OAAI
Empirical treatment with valganciclovir in infants living with HIV and hospitalised with severe pneumonia in Africa: a multicentre, open-label, factorial, randomised, controlled, superiority trial

在非洲,对感染HIV并因重症肺炎住院的婴儿使用缬更昔洛韦进行经验性治疗:一项多中心、开放标签、析因设计、随机对照、优效性试验

2026-07-170
OA
Pharmacokinetics and pharmacodynamics of valganciclovir in infants with severe HIV-associated pneumonia in Africa: a sub-study of the EMPIRICAL randomised controlled trial

非洲严重HIV相关肺炎婴儿中缬更昔洛韦的药代动力学和药效学研究:EMPIRICAL随机对照试验的子研究

2026-04-130
OAAI
Early inflammation as a footprint of increased mortality risk in infants living with HIV from three African countries
2024-10-281
OAAI
Analytical treatment interruption in children living with HIV: position statement from the EPIICAL consortium
2024-10-011
PRE
High mortality following early initiation of antiretroviral

早期开始抗逆转录病毒治疗后死亡率高

2024-07-013
OAAI
Sustained aviremia despite anti-retroviral therapy non-adherence in male children after in utero HIV transmission
2024-06-063
OAAI
Low unspliced cell-associated HIV RNA in early treated adolescents living with HIV on long suppressive ART
2024-02-201
OAAI
Laboratory diagnosis of Pneumocystis jirovecii in HIV-positive infants with severe pneumonia using non-invasive samples
2023-12-170
OA
High mortality in African infants living with HIV hospitalized with severe pneumonia
2023-12-170
OA
Building a national network for inpatient pediatric clinical research in Mozambique
2023-12-170
OA
Plasma concentrations of first line antituberculosis drugs in infants with HIV and severe pneumonia: a pharmacokinetic sub-study of the empirical trial
2023-12-170
OA
Position statement on infection screening, prophylaxis, and vaccination of pediatric patients with rheumatic diseases and immunosuppressive therapies, part 3: precautions in situations of surgery, fever, and opportunistic infections
2023-12-040
OAAI